Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$14.73 - $35.25 $1.78 Million - $4.25 Million
-120,622 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$33.72 - $48.22 $24,784 - $35,441
735 Added 0.61%
120,622 $4.14 Million
Q3 2021

Nov 10, 2021

SELL
$49.26 - $74.5 $45,368 - $68,614
-921 Reduced 0.76%
119,887 $6.55 Million
Q2 2021

Aug 13, 2021

SELL
$56.91 - $127.53 $5.51 Million - $12.4 Million
-96,886 Reduced 44.51%
120,808 $8.88 Million
Q1 2021

May 14, 2021

BUY
$79.79 - $126.29 $14.9 Million - $23.6 Million
186,936 Added 607.76%
217,694 $19.9 Million
Q4 2020

Feb 02, 2021

SELL
$46.76 - $136.27 $28,056 - $81,762
-600 Reduced 1.91%
30,758 $2.49 Million
Q3 2020

Nov 05, 2020

BUY
$43.8 - $77.2 $1.37 Million - $2.42 Million
31,358 New
31,358 $1.46 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.